Literature DB >> 2667373

Granuloma formation by artificial microparticles in vitro. Macrophages and monokines play a critical role in granuloma formation.

Y Shikama1, K Kobayashi, K Kasahara, S Kaga, M Hashimoto, I Yoneya, S Hosoda, K Soejima, H Ide, T Takahashi.   

Abstract

To investigate the basic mechanisms of granuloma formation, in vitro granulomas were induced by culturing murine spleen cells in the presence of artificial microparticles. Large granulomas developed around dextran beads. The lesions were inducible by spleen cells from either normal mice or athymic nude mice. Minimal inflammation was produced around latex beads. The histologic features and time kinetics of granulomas in vitro. Culture supernatants of dextran induced granulomas contained high levels of interleukin-1 (IL-1) activity but not interleukin-2 (IL-2) or interleukin-4 (IL-4) activity. IL-1 activity was correlated with granuloma size. Additionally, granulomas were produced by culturing spleen cells in the presence of agarose beads coupled to recombinant IL-1 or recombinant tumor necrosis factor-alpha (TNF-alpha). Granulomatous lesions also were induced by macrophage-enriched populations in the presence of monokine-coupled beads. Adherent macrophages, but not nonadherent cells, were required for induction of granulomas in vitro. In contrast, very small lesions were seen when spleen cells or adherent cells were cultured in the presence of beads coupled to recombinant IL-2 or recombinant interferon-gamma (IFN-gamma). These results suggest that macrophages and monokines such as IL-1 and TNF-alpha play an essential role in granuloma formation in vitro.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2667373      PMCID: PMC1879943     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

Review 1.  Lymphokines.

Authors:  C A Dinarello; J W Mier
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

Review 2.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

Review 3.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

Review 4.  Structure and function of interleukin 4 and 5.

Authors:  P Sideras; T Noma; T Honjo
Journal:  Immunol Rev       Date:  1988-02       Impact factor: 12.988

5.  Enhancement of DNA synthesis and cAMP content of mouse thymocytes by mediator(s) derived from adherent cells.

Authors:  J J Oppenheim; A Shneyour; A I Kook
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

6.  Characterization of regulatory (interferon-alpha/beta) and accessory (LAF/IL 1) monokine activities from liver granuloma macrophages of Schistosoma mansoni-infected mice.

Authors:  D E Elliott; V F Righthand; D L Boros
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

7.  Tumor necrosis factor production by human sarcoid alveolar macrophages.

Authors:  P R Bachwich; J P Lynch; J Larrick; M Spengler; S L Kunkel
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

Review 8.  Biology of interleukin 1.

Authors:  C A Dinarello
Journal:  FASEB J       Date:  1988-02       Impact factor: 5.191

9.  Immunohistochemical analysis of sarcoid granulomas. Evaluation of Ki67+ and interleukin-1+ cells.

Authors:  M Chilosi; F Menestrina; P Capelli; L Montagna; M Lestani; G Pizzolo; A Cipriani; C Agostini; L Trentin; R Zambello
Journal:  Am J Pathol       Date:  1988-05       Impact factor: 4.307

10.  Direct evidence for granuloma-inducing activity of interleukin-1. Induction of experimental pulmonary granuloma formation in mice by interleukin-1-coupled beads.

Authors:  K Kasahara; K Kobayashi; Y Shikama; I Yoneya; K Soezima; H Ide; T Takahashi
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

View more
  15 in total

1.  Multinucleated giant cells in primary cultures derived from canine bone marrow--evidence for formation of putative osteoclasts.

Authors:  M C Bird; D Garside; H B Jones
Journal:  Cell Tissue Res       Date:  1992-04       Impact factor: 5.249

2.  Generation of multinucleated giant cells in vitro by culture of human monocytes with Mycobacterium bovis BCG in combination with cytokine-containing supernatants.

Authors:  A Gasser; J Möst
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Trehalose 6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensitivity-type granulomas in mice.

Authors:  H Yamagami; T Matsumoto; N Fujiwara; T Arakawa; K Kaneda; I Yano; K Kobayashi
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

4.  Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy.

Authors:  S Brahmbhatt; G F Black; N M Carroll; N Beyers; F Salker; M Kidd; P T Lukey; K Duncan; P van Helden; G Walzl
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

5.  Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.

Authors:  M Z Mazlam; H J Hodgson
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

6.  The role of macrophage colony-stimulating factor in hepatic glucan-induced granuloma formation in the osteopetrosis mutant mouse defective in the production of macrophage colony-stimulating factor.

Authors:  K Takahashi; M Naito; S Umeda; L D Shultz
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

7.  Tumour necrosis factor production in vivo and in vitro in response to Paracoccidioides brasiliensis and the cell wall fractions thereof.

Authors:  F Figueiredo; L M Alves; C L Silva
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

8.  In vivo expression of monokine and inducible nitric oxide synthase in experimentally induced pulmonary granulomatous inflammation. Evidence for sequential production of interleukin-1, inducible nitric oxide synthase, and tumor necrosis factor.

Authors:  M Tsuji; V B Dimov; T Yoshida
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

9.  Suppression of pulmonary granulomatous inflammation by immunomodulating agents.

Authors:  M Hashimoto; K Kobayashi; N Yamagata; T Katsura; S Sugihara; H Iwabuchi; T Kasama; K Kasahara; T Takahashi; K Takeshita
Journal:  Agents Actions       Date:  1992-09

10.  Isolation and characterization of granuloma initiation factor.

Authors:  M A Fung; N Sato; T Tida; K Fukuyama; W L Epstein
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.